Skip to main content
Gut logoLink to Gut
letter
. 2005 Feb;54(2):312–313. doi: 10.1136/gut.2004.049767

Microscopic (collagenous and lymphocytic) colitis triggered by food allergy

M Weidenhiller 1, S Müller 2, D Schwab 3, E G Hahn 3, M Raithel 3, S Winterkamp 4
PMCID: PMC1774829  PMID: 15647205

Collagenous and lymphocytic colitis1,2 are rare3 diseases of unknown aetiology but several issues,1–3,5 in particular the good response to budesonide,7 are suggestive of immunopathology. Patients have watery diarrhoea without abnormal findings on colonoscopy1–5 but with increased numbers of intraepithelial lymphocytes, mast cells, and eosinophils5 on histological examination.

We report six patients seen between 1993 and 1999 who were first diagnosed as having collagenous/lymphocytic colitis. Signs of allergy entailed a work up for food allergy. (table 1)

Table 1.

 Patient characteristics

Sex Age (y) Follow up (y) Atopy Signs of allergy Diagnostic markers suggestive of allergy Identified allergen
F 49 5 + Improvement by hypoallergenic diet Eos in bx Egg, pollen, housedust mite
M 45 5 Urticaria, improvement by cromolyn UMH
M 46 5 Pansinusitis Eos in bx Spices, moulds, flours, celery, nuts, milk, maize, rice, apple, celery, soy
M 52 3 IgG deficiency Eos in bx Maize starch
M 71 9 + Prick Prick, RAST Milk, egg, soy
F 59 4 + Prick UMH Ananas

Eos in bx, eosinophils in colon biopsy; UMH, urine methylhistamine.

All patients were investigated with skin prick testing, total and allergen specific IgE with food, and environmental allergens. Excretion of urine methylhistamine (UMH) was measured8 on a normal and hypoallergenic potato-rice diet. Colonoscopy with endoscopically guided segmental lavage for intestinal IgE was carried out9 and biopsies were investigated by routine pathology (haematoxylin-eosin), immunohistochemistry for eosinophil peroxidase, and amount of eosinophil cationic protein and tryptase9 in the whole biopsy. Clinical activity was mainly assessed by number of stools/day7 and the Karnofsky index for general performance.

After allergen identification, all patients were counselled on elimination of the allergen, except for one case where no allergen was identified. In this case, in a second patient with multiple sensitisations, and in a third with allergy to basal foods, additional cromolyn therapy was initiated. A trial of hypoallergenic diet and subsequent controlled addition of food with low allergenicity was performed. Additional antihistaminergic therapy (fexofenadine) was recommended as supplementary therapy for periods of exacerbation.

All patients were followed prospectively every 12 months after diagnosis (outpatient clinic and structured telephone interview) and all had symptom reduction in terms of stool frequency and consistency (table 2). General performance was completely restored in four patients and improved in one. The remaining patient is still very restricted in his activities due to incapacitating coronary artery disease but his gastrointestinal symptoms are tolerable.

Table 2.

 Number of stools per day (Baerts score7)before and after therapy

Sex Age (y) Before diagnosis After diagnosis
F 49 5–10 1–2
M 45 5 0
M 46 4–6 0–1
M 52 10 1
M 71 4 1
F 59 5 1

Another patient was not willing to undergo colonoscopy for lavage and allergen identification, nor willing to quit smoking. His stools normalised after a six month course of cromolyn but he still suffers from bouts of diarrhoea during stress. He considers his general performance as good.

Histology was available for one patient before and after therapy. After dietary elimination, eosinophilic infiltrate was markedly less dense and degranulated.

The mechanisms of diarrhoea in collagenous colitis include a pronounced diffusion barrier with diminished net absorption of sodium and chloride ions.6 Allergens could induce increased eosinophil infiltration and enhance transforming growth factor β10 with increased collagen deposition. Eosinophils are highly susceptible to steroids which may explain the good response of collagenous colitis to budesonide.4

In summary, a subgroup of patients with microscopic colitis suffer from food allergy. Further work up for allergy is sensible in those patients with a history of atopic disease or blood/tissue eosinophilia. Allergen elimination can decrease or abolish the need for medication. Antiallergic therapy can be added to the therapeutic regimen.

Supplementary Material

[Conflict of Interest Statement]

References

  • 1.Lindström CG. “Collageous colitis” with watery diarrhea—a new entity. Pathol Eur 1976;11:87–9. [PubMed] [Google Scholar]
  • 2.Read NW, Krejs GJ, Read MG, et al. Chronic diarrhea of unknown origin. Gastroenterology 1980;78:264–71. [PubMed] [Google Scholar]
  • 3.Fernandez-Banares F , Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999;94:418–23. [DOI] [PubMed] [Google Scholar]
  • 4.Schwab D , Raithel M, Hahn EG. Kollagene und lymphozytäre Kolitis (Collagenous and lymphocytic colitis). Deut Med Wochenschrift 1998;123:1285–91. [DOI] [PubMed] [Google Scholar]
  • 5.Schiller LR. Pathophysiology and treatment of microscopic-colitis syndrome. Lancet 2000;355:1198–9. [DOI] [PubMed] [Google Scholar]
  • 6.Bonderup OK, Folkersen BH, Gjersoe P, et al. Collagenous colitis: a long-term follow-up study. Eur J Gastroenterol Hepatol 1999;11:493–5. [PubMed] [Google Scholar]
  • 7.Baert F , Wouters K, D’Haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002;122:20–5. [DOI] [PubMed] [Google Scholar]
  • 8.Weidenhiller M , Stolper J, Winterkamp S, et al. Urine-methylhistamine as an ambulant, non-invasive marker for food allergy. Gut 2001;49 (suppl III) :2764. [Google Scholar]
  • 9.Schwab D , Raithel M, Klein P, et al. Immunoglobulin E and eosinophilic cationic protein in segmental lavage fluid of the small and large bowel identify patients with food allergy. Am J Gastroenterol 2001;96:508–14. [DOI] [PubMed] [Google Scholar]
  • 10.Sampson HA. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999;103:717–28. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Conflict of Interest Statement]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES